Related Experiment Video
Updated: Aug 14, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?
C Mayerat1, A Mantegani, P C Frei
1Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.
Insights
Hepatitis B virus (HBV) genotype A is strongly linked to chronic infections, while genotype D is associated with acute, resolving hepatitis. This finding suggests HBV genotypes influence infection outcomes and disease progression.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis B virus (HBV) infection can lead to chronic liver disease in 5-10% of adults.
- HBV genotypes A and D are prevalent in Western Europe, accounting for 90% of infections.
- The relationship between HBV genotype and clinical outcome requires further investigation.
Purpose of the Study:
- To investigate the association between HBV genotypes A and D and the clinical outcome of hepatitis B infection.
- To compare the prevalence of HBV genotypes A and D in patients with chronic active hepatitis versus acute resolving hepatitis.
Main Methods:
- Genotyping of HBV in patients with chronic active hepatitis and acute resolving hepatitis.
- Statistical analysis (Fisher's exact test) to determine the association between genotype and clinical outcome.
Main Results:
- HBV genotype A was prevalent in 28/35 patients with chronic active hepatitis.
- HBV genotype D was prevalent in 24/30 patients with acute resolving hepatitis.
- A statistically significant association was found between HBV genotype A and chronic infection (P < 0.0001).
Conclusions:
- HBV genotype A is significantly associated with chronic hepatitis B infection.
- HBV genotype D is significantly associated with acute, resolving hepatitis B infection.
- HBV genotypes may play a crucial role in the virus-host relationship and disease progression.
Abstract:
Between 5 and 10% of adults infected with the hepatitis B virus (HBV) develop a chronic infection lasting longer than 6 months, which may lead to advanced liver disease. HBV can be classified into six genotypic families: A, B, C, D, E and F, but only genotypes A and D are significantly represented in western Europe, where they account for some 90% of cases of infection with HBV. In the present study, we investigated a possible association between HBV genotype A or D and clinical outcome of the infection. We compared the prevalence of these genotypes in a group of patients with chronic active hepatitis to that of a group with acute resolving hepatitis. In patients with chronic active hepatitis, genotype A was found in 28 of 35 patients and genotype D in only four. The remaining three patients were infected with genotype non-A, non-D. In contrast, genotype D was found in 24 of 30 patients with acute hepatitis, whilst genotype A was found in only three patients of this group. Three were infected with genotype non-A, non-D. Our results show a clear association between genotype A and chronic outcome (Ficher's exact test: two-sided P-value, P < 0.0001). They suggest that HBV genotypes may play a role in the virus-host relationship. Possible mechanisms for such a role are discussed.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Viruses with RNA Genomes
Hepatitis
Genital Herpes
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction

